Contribute Try STAT+ Today

WASHINGTON — The Senate Finance Committee on Monday announced its second drug pricing hearing of 2019, with its leadership insisting on attendance from the executives of seven major drug manufacturers: AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Pfizer, and Sanofi.

At a hearing last week, both Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) expressed disappointment that pharmaceutical company executives had declined their invitations to testify. Grassley, the committee chairman, said then he would be “more insistent” that executives show up at a subsequent hearing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • The pharmaceutical acquisitiveness are totally out of control and our government allows them to get away with this sheer greediness, per recent Senate
    Hearings. This includes all so- called Health Care Professionals, what egotistical, narcissistic, Quack/ Horse Doctor came up with that Nomenclature and P.S. My Wife is a Doctor!!!

    • The pharmaceutical acquisitiveness are and have been totally out of control, and our government; allows them to get away with this sheer greediness, by bilking, and dunning of the American public; as per recent Senate Dog and Pony show Hearings. This includes all so- called Health Care Professionals; what egotistical, narcissistic, Quack/ Horse Doctor came up with that Nomenclature and P.S. My Wife is a Doctor!!!

  • Wouldn’t it be a better idea to get the 3 big PBM’s before congress and ask them why they stole billions of dollars from the Federal and 20 state governments ?

    • The whole supply chain should be questioned. No one in the US knows exactly what a drug costs. List prices should be listed so that everyone can see partial facts. Rebates to PBMS are bribery. Higher bribe, better is the chance to get on the formulary.

  • Our legislatures can do lot of song and dance and introduce bills and whatever about drug costs but when rubber meets the road NO ONE and I mean NO ONE will vote for the benefit of electorate. Our legalized corrupt system prevents them to think of the electorate. They only think we tried but failed.

  • On the proposal to allow importation of drugs from Canada for personal use, why should the taxpayers of Canada have to subsidize the drug costs for Americans? Part of why the prices are lower in Canada is because the government subsidizes the costs. While I’m all for lower drug costs, ripping off the Canadians shouldn’t be the way to do so.

    • Can you please document or reference your claim that Canadian Government subsidizes costs? I sure would like to learn. Thank you!

  • Funny that Lilly is not one of the companies invited. I “recall” that Sec. Azar was President of the U.S. division of Eli Lilly and Company, a major pharmaceutical drug company. Why not include Eli Lilly in this conversation?

Comments are closed.